These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4615809)

  • 1. Suppression of in vitro lymphocyte stimulation in mice bearing primary Moloney sarcoma virus-induced tumors.
    Kirchner H; Herberman RB; Glaser M; Lavrin DH
    Cell Immunol; 1974 Jul; 13(1):32-40. PubMed ID: 4615809
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus.
    Kirchner H; Chused TM; Herberman RB; Holden HT; Lavrin DH
    J Exp Med; 1974 Jun; 139(6):1473-87. PubMed ID: 4598016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to murine sarcoma virus-inducted tumors. II. Suppression of T cell-mediated immunity by cells from progressor animals.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1826-38. PubMed ID: 4361978
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of in vitro-stimulated immune lymphocytes in mice bearing Moloney murine sarcoma virus-induced primary tumor.
    Kimura H; Yamaguchi Y
    Gan; 1981 Feb; 72(1):72-80. PubMed ID: 7274651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated reactivity to antigens shared by Moloney-virus-induced lymphomas (LSTRA) and certain 3-methylcholanthrene-induced mouse sarcomas.
    Hellström I; Hellström KE; Zeidman L; Bernstein ID; Brown JP
    Int J Cancer; 1979 Apr; 23(4):555-64. PubMed ID: 86527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA tumor-virus antigen expression in chemically induced tumors. Virus-genome-specified common antigens detected by complement fixation in mouse tumors induced by 3-methylcholanthrene.
    Whitmire CE; Salerno RA; Rabstein LS; Huebner RJ; Turner HC
    J Natl Cancer Inst; 1971 Dec; 47(6):1255-65. PubMed ID: 4330465
    [No Abstract]   [Full Text] [Related]  

  • 7. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Jul; 12(1):233-41. PubMed ID: 4133585
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of Moloney sarcoma virus-induced tumor growth by concanavalin A.
    Davis S; Redmon LW; Pearson GR
    Immunol Commun; 1975; 4(1):29-37. PubMed ID: 1090515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered lymphocyte functions in rats bearing syngeneic Moloney sarcoma tumors. I. Mitogen responses, mixed lymphocyte reactions (MLR) and mixed lymphocyte-tumor reactions (MLTR).
    Veit BC; Feldman JD
    J Immunol; 1976 Aug; 117(2):646-54. PubMed ID: 133190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on cellular immunity and its serum mediated inhibition in Moloney-virus-induced mouse sarcomas.
    Hellström I; Hellström KE
    Int J Cancer; 1969 Sep; 4(5):587-600. PubMed ID: 5349009
    [No Abstract]   [Full Text] [Related]  

  • 11. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex.
    Enjuanes L; Lee JC; Ihle JN
    J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhancement of experimental tumors in mice by treatment with concanavalin A.
    Ekstedt RD
    J Natl Cancer Inst; 1979 Oct; 63(4):1065-9. PubMed ID: 480379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic or antgonistic effect of different antibody concentrations on in vitro lymphocyte cytotoxicity in the Moloney sarcoma virus system.
    Skurzak HM; Klein E; Yoshida TO; Lamon EW
    J Exp Med; 1972 Apr; 135(4):997-1002. PubMed ID: 5018057
    [No Abstract]   [Full Text] [Related]  

  • 14. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
    Cleveland PH; McKhann CF; Johnson K; Nelson S
    Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression in mice bearing primary tumors.
    Whitney RB; Kelly BS; Levy JG
    Eur J Cancer (1965); 1978 Jun; 14(6):699-705. PubMed ID: 658094
    [No Abstract]   [Full Text] [Related]  

  • 17. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors.
    Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385
    [No Abstract]   [Full Text] [Related]  

  • 18. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts.
    Kiessling R; Bataillon G; Lamon EW; Klein E
    Int J Cancer; 1974 Nov; 14(5):642-8. PubMed ID: 4459279
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of sera from tumor-bearing mice on mitogen and allogeneic cell stimulation of normal lymphoid cells.
    Whitney RB; Levy JG
    J Natl Cancer Inst; 1975 Mar; 54(3):733-41. PubMed ID: 123599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of colony-stimulating factor in mitogen-stimulated lymphocyte cultures.
    Parker JW; Metcalf D
    J Immunol; 1974 Feb; 112(2):502-10. PubMed ID: 4591973
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.